GB/T 29791.1-2013In vitro diagnostic medical devices -- Information supplied by the manufacturer (labelling) -- Part 1: Terms, definitions and general requirements (English PDF)
Also coversGBT29791.1-2013
Open the GB/T 29791.1-2013 preview as PDF
This is a limited preview
Buy now to download the full PDF
Issued by
General Administration of Quality Supervision, Inspection and Quarantine of the People's Republic of China, Standardization Administration of the People's Republic of China
Level / Type
National · Recommended
Issue date
October 10, 2013
Implementation date
February 1, 2014
Scope
GB/T 29791.1-2013 (In vitro diagnostic medical devices -- Information supplied by the manufacturer (labelling) -- Part 1: Terms, definitions and general requirements) is available as an English-translated PDF.
GB/T 29791.1-2013 — This section GB/T 29791 for information on the definition of the concept of in vitro diagnostic medical devices supplied by the manufacturer to establish the general principles and provisions basic requirements. Language belongs to the scope of national laws and regulations, we will not be discussed in this section. This section does not apply to. a) Performance evaluation of in vitro diagnostic medical devices (such as for research use only); b) instrument mark; c) safety data sheet.
Document preview — GB/T 29791.1-2013
National Standard of the People's Republic of China
- ICS
- 11.100
- Classification
- C 44
Issued by: General Administration of Quality Supervision, Inspection and Quarantine of the People's Republic of China, Standardization Administration of the People's Republic of China
Contents
- 1 Scope1
- 2 Normative references1
Foreword
GB/T 29791 "in vitro diagnostic medical devices - Information supplied by the manufacturer (labeling)" is divided into five parts.
--- Part 1. Terms, definitions and general requirements;
--- Part 2. In vitro diagnostic reagents for professional use;
--- Part 3. In vitro diagnostic instruments for professional use;
--- Part 4. In vitro diagnostic reagents for self;
--- Part 5. In vitro diagnostic instruments for self.
This section GB/T 29791 Part 1.
This section drafted in accordance with GB/T 1.1-2009 given rules.
This section uses the translation method identical with ISO 18113-1.2009 "in vitro diagnostic medical device manufacturers to provide information (labeling)
Part 1. Terms, definitions and general requirements. "
Consistency correspondence between this part of international documents and normative references of our files are as follows.
--- GB 3100-1993 International System of Units and Its Application (eqv ISO 1000.1992)
--- YY/T 0287-2003 medical device quality management system for regulatory requirements (ISO 13485.2003, IDT)
--- YY/T 0316-2008 medical device risk management to medical devices applications (ISO 14971.2007, IDT)
Symbols - Part 1 --- YY/T 0466.1-2009 medical equipment used with medical device labels, labeling and information provided. pass
With requirements (ISO 15223-1.2007, IDT)
Please note that some of the content of this document may involve patents. Release mechanism of the present document does not assume responsibility for the identification of these patents.
This part is proposed by the State Food and Drug Administration.
This part of the National Medical clinical testing laboratory and in-vitro diagnostic systems for Standardization Technical Committee (SAC/TC136) centralized.
This section is drafted. Beijing Medical Device Testing.
Introduction
Vitro diagnostic (IVD) medical device manufacturers can provide the user with the safe use of the instrument and the achievement of its expected performance information. Tradition
On the information provided to the label, package inserts and user manuals form. The form and level of detail generally depends on the intended use and the specific country
Global Harmonization Task Force (GHTF) encourages global regulatory system for medical devices to converge with the aim of promoting trade and at the same time guarantee
Members to stay involved in the form of regulations, the powers of public health protection. Consistent with worldwide labeling requirements may give manufacturers, users, patients
And regulatory authorities to bring significant benefits. Eliminate differences between jurisdictions and regulations can reduce the time required to obtain regulatory approval, which can make patients more
Ease of access to new technologies and treatments, see reference [36]. This section provides coordination vitro diagnostic medical devices on the basis of labeling requirements.
GHTF has established guidelines for medical device labeling, see Ref. [36]. These principles have been integrated into
GB/T 29791/ISO 18113 series of standards. Special attention is, GHTF recommends that the content of the labels and instructions for use, and format text
Style country-specific requirements should be kept to a minimum level, and eliminate these differences when mature over a period of time to be opportunities.
This section contains the vocabulary and terms to develop in vitro diagnostic medical devices labeled needed. If the international definition of the key concepts of reach
Consensus, will largely promote the in vitro diagnostic medical devices marked consistency. Although the goal is marked in vitro diagnostic medical devices in use
The standardization of terminology in the extent possible, but also recognizes that currently are considered national and regional medical laboratories, medical staff, patients and regulatory authorities
With usage must be respected.
In some countries, in vitro diagnostic medical devices timeliness and affordability barriers still request for information to appear in multiple languages. in
Any practicable, as long as the user will not reduce the terms of understanding the impact of the safe use of equipment, GHTF encourages the use of standards
Oriented, internationally recognized symbols. This standard is consistent with the target symbol GHTF support.
GHTF also encourages manufacturers to adopt the most appropriate way to release information. Until now most of the information that came to be in vitro diagnostic medical
Instruments to provide printed material. Modern technology makes use of technical information and instructions may be provided with a more efficient way. Digital information can be compiled
Code on magnetic or optical media, displayed on the screen of the device that contains, or even transfer when using the Internet. Such advances offer the user
More timely access to critical information may be provided, such as changes in performance and enables manufacturers to more efficient distribution of information.
GB/T 29791 series of standards provides for the in vitro diagnostic medical device manufacturers to provide information about the requirements of standards published in five parts,
It makes it the most appropriate way to focus on the specific needs of professional users and non-professional users. Further, since the manufacturer is an in vitro diagnostic
Off reagents and equipment to provide different types of information, their requirements described in a separate section of this series of standards.
This section is not intended to be used alone, it contains the term applies to GB/T 29791 all parts of the definitions and general requirements. Also in this
Appendixes A description is given in vitro diagnostic medical device performance characteristics of terms, definitions guidelines. This part of the information in GB/T 29791 Other
Section will not be repeated, so this part of the GB/T 29791.2, GB/T 29791.3, GB/T 29791.4, GB/T 29791.5 application is
Indispensable.
GB/T 29791.2 provisions of the labels and instructions for professional use in vitro diagnostic reagents, calibrators and control materials provided by request.
GB/T 29791.3 provides for labeling and instructions for use in vitro diagnostic instruments for professional use provided requirements. GB/T 29791.4 provides for self-test
Using an in vitro diagnostic reagents, calibrators and control materials provided by the labels and instructions for use requirements. GB/T 29791.5 provides for self-test use in vitro
Instructions for use of diagnostic requirements provided by the instrument.
GB/T 29791 Part 1, Part 2, Part 3 is the standard use of medical laboratories and other specialized needs.
GB/T 29791 Part 1, Part 4, Part 5 is the standard for self-vitro diagnostic medical devices needed. However, that manufacturing
Suppliers often provided by the instrument and a dedicated reagent system composed of these standards allow the most appropriate form of flexibility to raise user expectations
For the necessary information. For example, the integration of in vitro diagnostic medical devices in a single system manual.
In vitro diagnostic medical device manufacturers to provide information
(Flag) - Part 1. Terms, definitions and general requirements
1 Scope
This section GB/T 29791 for information on the definition of the concept of in vitro diagnostic medical devices supplied by the manufacturer to establish the general principles and provisions
basic requirements.
Language belongs to the scope of national laws and regulations, we will not be discussed in this section.
This section does not apply to.
a) Performance evaluation of in vitro diagnostic medical devices (such as for research use only);
b) instrument mark;
c) safety data sheet.
2 Normative references
The following documents for the application of this document is essential. For dated references, only the dated version suitable for use herein
Member. For undated references, the latest edition (including any amendments) applies to this document.
ISO 1000 SI units and their multiples and of certain other units of applications recommended (SIunitsandrecommendationsfor
theuseoftheirmultiplesandofcertainotherunits)
ISO 13485 medical device quality management system for regulatory requirements (Medicaldevices-Qualitymanagement
systems-Requirementsforregulatorypurposes)
ISO 14971 Medical Device Risk Management for Medical Device Applications (Medicaldevices-Applicationofriskmanage-
menttomedicaldevices)
ISO 15223-1 medical equipment with medical device labels, labeling and information provided by graphical symbols - Part 1. General requirements
(Medicaldevices-Symbolstobeusedwithmedicaldevicelabels, labelingandinformationtobesup-
plied-Part 1. Generalrequirements)
IEC 62366 Medical Devices to use engineering applications (Medicaldevices-Applicationofusability on medical devices
engineeringtomedicaldevices)
EN980 medical devices used in the labeling symbol (Symbolsforuseinthelabelingofmedicaldevices)
3 Terms and Definitions
For this portion, and GB/T 29791.2 ~ 29791.5, the following terms and definitions apply. However, given the national and regional regulations
The definition should be used in preference. Information and when the use of international standards in terms and definitions, in vitro diagnostic medical devices supplied by the manufacturer
Terms and definitions used should comply with the requirements of 4.6.2.
When synonyms are given, each term can be used, but it is best to use the first term.
Some definitions in accordance with the relevant in vitro diagnostic label or term in order to meet ISO rules must be modified, in this case, explanatory notes
Definition has been adapted and gives references
In some cases, existing Notes requires additional notes or modified to illustrate the applicability of the in vitro diagnostic medical devices, as well as provincial
Omitted some notes do not apply to in vitro diagnostic medical devices, these cases are not considered to be modified and are not defined as "adaptation."
......
This preview omits tables, figures, formulas and parts of the technical clauses. The complete document — all pages — is available in the English PDF.
Referenced standards
Normative references
ISO 1000 · ISO 13485 · ISO 14971 · ISO 15223 · IEC 62366
Cited by
- YY/T 1969-2025Microalbumin testing kit (immunoturbidimetry)
- YY/T 1970-2025Lipoprotein-associated phospholipase A2 testing kit (chemiluminescent immunoassay)
- YY/T 1233-2024Cardiac troponin detection reagent kit (labelled immunoassay)
- YY/T 1256-2024Ureaplasma nucleic acid detection kit
- YY/T 1199-2023Triglycerides assay kit (enzymic method)
- YY/T 1890-2023Hepatitis B virus surface antigen detection kit (immunochromatography)
How to Buy GB/T 29791.1-2013
- 1Add to cart. Click the "Buy GB/T 29791.1-2013" button on this page. You can add more standards before checkout.
- 2Checkout. Enter your email and billing details. Payment is processed securely by Stripe (cards, Apple Pay, Google Pay supported).
- 3Instant delivery (0–9 sec). Delivery is automatic: within seconds of payment you'll receive an email with a secure download link. The link stays valid for 72 hours.
- 4Invoice included. A tax invoice is attached to the confirmation email. Need a custom invoice? Contact us.
Related Standards
GB/T 29791.2-2013 — In vitro diagnostic medical devices -- Information supplied by the manufacturer (labelling) -- Part 2: In vitro diagnostic reagents for professional use
GB/T 29791.3-2013 — In vitro diagnostic medical devices -- Information supplied by the manufacturer (labelling) -- Part 3: In vitro diagnostic instruments for professional use
GB/T 29791.4-2013 — In vitro diagnostic medical devices -- Information supplied by the manufacturer (labelling) -- Part 4: In vitro diagnostic reagents for self-testing
Secure payment via Stripe
Payments accepted
GB/T 29791.1-2013
$600.00